Solubilization and purification of rat liver microsomal 1,2-diacylglycerol: CDP-choline cholinephosphotransferase and 1,2-diacylglycerol: CDP-ethanolamine ethanolaminephosphotransferase.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMID 182489)

Published in Eur J Biochem on June 15, 1976

Authors

H Kanoh, K Ohno

Articles by these authors

Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66

Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55

The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45

Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus. Mol Cell Biol (1989) 2.33

Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science (2013) 2.33

Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25

Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet (1990) 1.98

[The fecal flora of man. IV. Communication: Comparison of the newly developed method with the old conventional method for the analysis of intestinal flora (author's transl)]. Zentralbl Bakteriol Orig A (1976) 1.79

Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77

Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy. Biochem Biophys Res Commun (1991) 1.70

New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60

Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci (1997) 1.59

Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet (1999) 1.57

Porcine diacylglycerol kinase sequence has zinc finger and E-F hand motifs. Nature (1990) 1.57

dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. Biochem Biophys Res Commun (1998) 1.54

Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun (1991) 1.49

Tensile and viscoelastic properties of human patellar tendon. J Orthop Res (1994) 1.49

Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy. Biochem Biophys Res Commun (1988) 1.48

Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol (1978) 1.43

GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet (1990) 1.43

Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744. J Bacteriol (1994) 1.42

Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci (1999) 1.42

Diacylglycerol kinase from pig brain. Purification and phospholipid dependencies. J Biol Chem (1983) 1.41

Congenital hydrocephalus due to intrauterine HTLV-I infection. Lancet (1990) 1.40

Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem (1996) 1.40

Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J Biol Chem (1995) 1.35

Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet (2001) 1.34

Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J Biol Chem (1997) 1.34

Mitochondrial DNA mutations in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem Biophys Res Commun (1991) 1.34

Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol (1980) 1.33

Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl (2003) 1.33

Bartonella henselae infection from a dog. Lancet (1998) 1.32

The differential expression patterns of messenger RNAs encoding K-Cl cotransporters (KCC1,2) and Na-K-2Cl cotransporter (NKCC1) in the rat nervous system. Neuroscience (2001) 1.30

Effect of light-adaptation on the photoreaction of bacteriorhodopsin from Halobacterium halobium. Biochim Biophys Acta (1977) 1.30

A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg (1985) 1.29

Determination of diamines and polyamines in tissues by high-pressure liquid chromatography. J Chromatogr (1976) 1.29

Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells. Proc Natl Acad Sci U S A (2001) 1.28

Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J Biol Chem (1993) 1.24

Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochem Pharmacol (2000) 1.24

NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C. Hum Genet (1999) 1.23

Separation of the Dns derivatives of polyamines and related compounds by thin-layer and high-pressure liquid chromatography. J Chromatogr (1975) 1.21

Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol (2000) 1.18

Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplification of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase. J Biol Chem (1996) 1.18

Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit. Neuron (1998) 1.17

Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood (1991) 1.16

Molecules in focus: diacylglycerol kinase. Int J Biochem Cell Biol (1997) 1.15

Phosphatidic acid generation through interleukin 2 (IL-2)-induced alpha-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation. J Biol Chem (1996) 1.15

Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg (1985) 1.15

End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann Neurol (1996) 1.15

Gene cloning, sequence, expression and in situ localization of 80 kDa diacylglycerol kinase specific to oligodendrocyte of rat brain. Brain Res Mol Brain Res (1992) 1.14

RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene (2006) 1.14

Brain edema during ischemia and after restoration of blood flow. Measurement of water, sodium, potassium content and plasma protein permeability. Stroke (1980) 1.14

[Interdural dermoid cyst of the cavernous sinus presenting with oculomotor palsy: case report]. No Shinkei Geka (1997) 1.14

Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. J Pharmacol Exp Ther (1987) 1.12

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun (1990) 1.12

Silk gland factor-1 involved in the regulation of Bombyx sericin-1 gene contains fork head motif. J Biol Chem (1995) 1.12

Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem (2000) 1.12

Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. J Pharmacol Exp Ther (1986) 1.11

Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. EMBO J (1997) 1.10

Immunological characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain. J Biol Chem (1986) 1.10

Blue light effect on proton pumping by bacteriorhodopsin. Biophys J (1983) 1.10

Porcine 80-kDa diacylglycerol kinase is a calcium-binding and calcium/phospholipid-dependent enzyme and undergoes calcium-dependent translocation. J Biol Chem (1991) 1.10

The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain. Biochem J (1996) 1.09

Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J Biol Chem (2001) 1.08

A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol (1981) 1.07

Prolonged lifetime of the 410-nm intermediate of bacteriorhodopsin in the presence of guanidine hydrochloride. Biochem Biophys Res Commun (1977) 1.07

Nearest neighbour analysis of MCM protein complexes in Drosophila melanogaster. Nucleic Acids Res (2001) 1.06

Air oxidation effects on microporosity, surface property, and CH4 adsorptivity of pitch-based activated carbon fibers. J Colloid Interface Sci (2004) 1.05

Distribution of referred pain from the lumbar zygapophyseal joints and dorsal rami. Clin J Pain (1997) 1.05

GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. Biochem Biophys Res Commun (1988) 1.04

Drug entry into the brain. Brain Res (1979) 1.04

Substrate-selectivity of rat liver microsomal 1,2-diacylglycerol: CDP-choline(ethanolamine) choline(ethanolamine)phosphotransferase in utilizing endogenous substrates. Biochim Biophys Acta (1975) 1.03

Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg (1988) 1.03

Mediastinal bronchial artery aneurysm with hematemesis. Dis Esophagus (2003) 1.02

Molecular cloning of a diacylglycerol kinase isozyme predominantly expressed in human retina with a truncated and inactive enzyme expression in most other human cells. J Biol Chem (1994) 1.02

Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS Lett (1989) 1.02

Free D-amino acids in human plasma in relation to senescence and renal diseases. Clin Sci (Lond) (1987) 1.02

In vivo observation of subendocardial microvessels of the beating porcine heart using a needle-probe videomicroscope with a CCD camera. Circ Res (1993) 1.02

A point mutation in the coding sequence of the beta-hexosaminidase alpha gene results in defective processing of the enzyme protein in an unusual GM2-gangliosidosis variant. J Neurochem (1988) 1.02

Paediatric CT examinations in 19 developing countries: frequency and radiation dose. Radiat Prot Dosimetry (2010) 1.01

Patient doses in CT examinations in 18 countries: initial results from International Atomic Energy Agency projects. Radiat Prot Dosimetry (2009) 1.01

Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev (1990) 1.01

Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1. Oncogene (2008) 1.01

Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients. Neurology (2009) 1.00

Chronological changes in brain edema induced by experimental intracerebral hematoma in cats. Acta Neurochir Suppl (Wien) (1994) 1.00

Myasthenic syndrome caused by plectinopathy. Neurology (2011) 1.00

Polyamine metabolism III: urinary acetyl polyamines in human cancer. J Pharm Sci (1978) 1.00

Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg (1986) 1.00

Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. J Clin Invest (1999) 0.99

Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors. J Virol (1998) 0.99

Effect of the removal of the COOH-terminal region of bacteriorhodopsin on its light-induced H+ changes. Biophys J (1982) 0.98

Genotype-phenotype relationship of Niemann-Pick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts. J Med Genet (2000) 0.98

A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: a new patient with 3.2 Mb deletion. J Med Genet (2009) 0.97

Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord (2002) 0.97

A comparison of surgical and prosthetic treatment for speech disorders attributable to surgically acquired soft palate defects. J Oral Maxillofac Surg (1993) 0.97

Functional indications for bullectomy of giant bulla. Ann Thorac Surg (1983) 0.97

Cell surface activities of the human type 2b phosphatidic acid phosphatase. J Biochem (2000) 0.97